Assignee
OPIANT PHARMACEUTICALS INC
US·3 granted patents·12 pending applications·20 citations·filing 2016–2023
Top patents by PatentIndex Score
15 records- 0195US9629965B2Nasal drug products and methods of their useOPIANT PHARMACEUTICALS INC·Filed 2016·Granted Apr 25, 2017·18 cites·30 claims
- 0286US11458091B2Compositions and methods for the treatment of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2017·Granted Oct 4, 2022·2 cites·15 claims
- 0375US2023225961A1Methods, Parenteral Pharmaceutical Formulations, and Devices for the Prevention of Opioid OverdoseOPIANT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0471US2022387306A1Compositions and methods for the treatment of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0570US2021275519A1Nasal drug products and methods of their useOPIANT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0669US2021401827A1Methods, parenteral pharmaceutical formulations, and devices for the prevention of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 0768US2023077724A1Methods and compositions for treating cannabinoid overdose with a cannabinoid receptor antagonistOPIANT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0867US2021275444A1Methods, parenteral pharmaceutical formulations, and devices for the prevention of opioid overdoseOPIANT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0966US11471437B2Compositions and methods for treating cannabinoid hyperemesis syndrome with a cannabinoid receptor antagonistOPIANT PHARMACEUTICALS INC·Filed 2020·Granted Oct 18, 2022·0 cites·26 claims
- 1065US2017304295A1Nasal drug products and methods of their useOPIANT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1156US2019262263A1Compositions, devices and methods for the treatment of opioid-receptor-mediated conditionsOPIANT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1254US2018169006A1Co-packaged drug productsOPIANT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1351US2020397749A1Compositions and methods for treating acute cannabinoid overdose with a cannabinoid receptor antagonistOPIANT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1446US2020179271A1Compositions and methods for treating acute cannabinoid overdose with a cannabinoid receptor antagonistOPIANT PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1539US2019209464A1Compositions, devices and methods for the treatment of alcohol use disorderOPIANT PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →